ATTOGENE CORPORATION

AUSTIN, TX · Medtech · Still private

A portable lateral flow diagnostic assay that detects malaria through hemozoin biomarker recognition and gold nanoparticle signal amplification, requiring no external equipment or sample preparation.

Claim this profile

Follows are private to you and power your alerts

Updated · attogene.com

Sector
Medtech
Headquarters
AUSTIN, TX
Total capital
$1.9M
Federal grants
$1.9M
8 awards · 2019–2025
Rank in peer group#241 of 445
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2019202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $1.9M$259K$249K$249K$257K
2019202120232025FEDERAL ↑EQUITY ↓Cumulative $1.9M$259K$249K$257K

Latest events

  • Federal grantHealth and Human S · Phase I · Development of a novel electrochemical pesticide sensor$257K
  • Federal grantHealth and Human S · Phase I · Lateral Flow Assay to Detect Malaria$249K
  • Federal grantHealth and Human S · Phase I · Convenient rapid and portable tool for the detection of ribonucleases$230K
  • Federal grantHealth and Human S · Phase I · Convenient rapid and portable tool for the detection of ribonucleases$230K
  • Federal grantHealth and Human S · Phase I · PA22176, SBIR, Phase I, Lateral Flow Assay to Detect Malaria$249K
  • Federal grantHealth and Human S · Phase I · Development of a rapid screening test for the detection of dihydroanatoxin-a$259K
  • Federal grantNSF · Phase I · SBIR Phase I: Development of a portable, sensitive, user-friendly electrochemical biosensor for detecting Pesticide residues$225K
Show 1 earlier federal award
  • Federal grantHealth and Human S · Phase I · Development of a rapid diagnostic assay for Myasthenia Gravis$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Attogene CorpShares a founder: Lance P Ford
  • VECTOR SURGICAL, LLCSimilar federal contract value in Medtech · null in contracts
  • FEMASYS INCSimilar federal contract value in Medtech · null in contracts
  • GametoSimilar federal contract value in Medtech · null in contracts
  • TMRW Life Sciences, Inc.Similar federal contract value in Medtech · null in contracts
  • CICERODX, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .